Translation and validation of the Traditional Chinese version of the COmprehensive Score for financial Toxicity-Functional Assessment of Chronic Illness Therapy (Version 2)

Chan, Dorothy N.S., Choi, Kai Chow, Ng, Marques S.N., Xing, Weijie, Law, Bernard M.H., Ho, Pui Shan, Au, Cecilia, Chan, Mandy, Tong, Man, Ling, Wai Man, Chan, Maggie, Mak, Suzanne S.S., , & So, Winnie K.W. (2021) Translation and validation of the Traditional Chinese version of the COmprehensive Score for financial Toxicity-Functional Assessment of Chronic Illness Therapy (Version 2). Health and Quality of Life Outcomes, 19, Article number: 17.

[img]
Preview
Published Version (PDF 856kB)
81255603.
Available under License Creative Commons Attribution 4.0.

Open access copy at publisher website

Description

<p>Background: Cancer patients often experience severe financial distress due to the high cost of their treatment, and strategies are needed to objectively measure this financial distress. The COmprehensive Score for financial Toxicity-Functional Assessment of Chronic Illness Therapy (COST-FACIT) is one instrument used to measure such financial distress. This study aimed to translate the COST-FACIT (Version 2) [COST-FACIT-v2] instrument into traditional Chinese (COST-FACIT-v2 [TC]) and evaluate its psychometric properties. Methods: The Functional Assessment of Chronic Illness Therapy (FACIT) translation method was adopted. The translated version was reviewed by an expert panel and by 20 cancer patients for content validity and face validity, respectively, and 640 cancer patients, recruited from three oncology departments, completed the translated scale. Its reliability was evaluated in terms of internal consistency and test–retest reliability. Confirmatory factor analysis has been used to evaluate the one- and two-factor structures of the instrument reported in the literature. The convergent validity was examined by the correlation with health-related quality of life (HRQoL) and psychological distress. Known-group validity was examined by the difference in the COST-FACIT-v2 (TC) total mean score between groups with different income levels and frequency of health care service use. Results: The COST-FACIT-v2 (TC) showed good content and face validity and demonstrated high internal consistency (Cronbach’s alpha, 0.86) and acceptable test–retest reliability (intraclass correlation coefficient, 0.71). Confirmatory factor analysis showed that the one- and two-factor structures of the instrument that have been reported in the literature could not be satisfactorily fitted to the data. Psychological distress correlated significantly with the COST-FACIT-v2 (TC) score (r = 0.47; p < 0.001). HRQOL showed a weak to moderate negative correlation with the COST-FACIT-v2 (TC) score (r = − 0.23 to − 0.46; p < 0.001). Significant differences were seen among the COST-FACIT-v2 (TC) scores obtained in groups of different income level and frequency of health care service use. Conclusions: The COST-FACIT-v2 (TC) showed some desirable psychometric properties to support its validity and reliability for assessing cancer patients’ level of financial toxicity.</p>

Impact and interest:

13 citations in Scopus
8 citations in Web of Science®
Search Google Scholar™

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

Full-text downloads:

72 since deposited on 13 Apr 2021
30 in the past twelve months

Full-text downloads displays the total number of times this work’s files (e.g., a PDF) have been downloaded from QUT ePrints as well as the number of downloads in the previous 365 days. The count includes downloads for all files if a work has more than one.

ID Code: 209584
Item Type: Contribution to Journal (Journal Article)
Refereed: Yes
ORCID iD:
Chan, Raymond J.orcid.org/0000-0003-0248-7046
Additional Information: Funding Information: This study was funded by The Chinese University of Hong Kong (reference number: CA-1806). The funding institution provided financial support for the research. The funding institution had no role in the study design, the data collection and analysis, the decision to publish or the preparation of the manuscript.
Measurements or Duration: 10 pages
Keywords: Comprehensive score for financial toxicity, Psychometric testing, Reliability, Validity
DOI: 10.1186/s12955-020-01646-z
ISSN: 1477-7525
Pure ID: 81255603
Divisions: Current > Research Centres > Centre for Healthcare Transformation
Current > Research Centres > Cancer and Palliative Care Outcomes Centre
Current > QUT Faculties and Divisions > Faculty of Health
Current > Schools > School of Nursing
Funding Information: The most common source of financial support for cancer treatment for the patients in this study was their personal savings, followed by funding under the social security allowance scheme, financial support from their children and personal medical insurance. These finance sources seem sufficient for the expenditures from cancer treatment in the short term. However, patients also considered their long-term expenditures because their savings may eventually be depleted, and their medical insurance may not be adequate to cover the required expenditures thereafter. In addition, most of the patients were not employed during the recruitment period, which further exacerbated their concerns over their ability to pay for further treatment and care. To meet the needs of their present treatment and prepare for the future, patients may have to adopt some coping strategies, such as application for additional financial assistance and reducing expenditures, to cope with the financial burden [, ]. It may also be worthwhile for the government to revisit the current financial assistance and the co-payment mechanism under certain funds, such as the Samaritan Fund and the Community Care Fund medical assistance programs [], to address the financial hardship faced by these patients.
Copyright Owner: 2021 The Author(s)
Copyright Statement: This work is covered by copyright. Unless the document is being made available under a Creative Commons Licence, you must assume that re-use is limited to personal use and that permission from the copyright owner must be obtained for all other uses. If the document is available under a Creative Commons License (or other specified license) then refer to the Licence for details of permitted re-use. It is a condition of access that users recognise and abide by the legal requirements associated with these rights. If you believe that this work infringes copyright please provide details by email to qut.copyright@qut.edu.au
Deposited On: 13 Apr 2021 00:18
Last Modified: 02 Jul 2024 01:37